Ablaze Pharmaceuticals

About:

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.

Website: http://www.ablazepharma.com/

Top Investors: Samsara BioCapital, venBio Partners, Vivo Capital, Venrock Healthcare Capital Partners, Advantech Capital

Description:

Ablaze Pharma is a clinical stage bio-pharmaceutical company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients.

Total Funding Amount:

$75M

Headquarters Location:

Jingan, Shanghai, China

Founded Date:

2011-04-01

Founders:

Ken Song

Number of Employees:

11-50

Last Funding Date:

2021-11-29

IPO Status:

Private

Industries: